Insider trading

Period: 12 months Role: Other officers × Minimum amount: $10M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

497 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

497 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

497 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

497 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
497 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
497 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

497 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Mar 2026
Venturo Brian M Chief Strategy Officer · indirect
Sold on a plan 5×
$22.31M 281,250 at 79.33
100%
Sold half or more
4 Mar 2026
Zeiler Gerhard President, International
Sold at will
$16.81M 600,000 at 28.02
47.1%
Not planned
4 Mar 2026
Musser Fory Senior VP, Development
Sold at will
$10.90M 1,000,000 at 10.90
100%
Sold half or more
2 Mar 2026
Notman Tali CHIEF REVENUE OFFICER
Sold at will
$143.96M 35,856 at 4,015.00
4.4%
Not planned
2 Mar 2026
NELSON MARK A Vice Chairman
Sold at will 2×
$26.23M 139,600 at 187.92
92.5%
Sold half or more
2 Mar 2026
DOUBLES BRIAN D See remarks
Sold on a plan 3×
$14.94M 217,554 at 68.68
20.8%
Planned (10b5-1)
2 Mar 2026
Tarbert Heath President
Sold on a plan 6×
$11.50M 122,007 at 94.23
16.9%
Planned (10b5-1)
2 Mar 2026
Reynal Vicente See Remarks
Sold on a plan
$11.11M 118,044 at 94.11
36.0%
Planned (10b5-1)
2 Mar 2026
Pate R. Hewitt Chief Legal Officer
Sold on a plan 3×
$10.94M 58,000 at 188.65
87.1%
Sold half or more
26 Feb 2026
Santos Esteban EVP, Operations
Sold at will 2×
$20.77M 54,792 at 379.12
41.7%
Not planned
26 Feb 2026
Patil Neena M EVP & Chief Legal Officer
Sold at will 11×
$10.65M 55,600 at 191.56
49.4%
Not planned
26 Feb 2026
COTE DAVID M Executive Chairman · indirect
Sold at will 8×
$10.21M 40,000 at 255.29
64.2%
Sold half or more
25 Feb 2026
Juniper Investment Company, LLC Affiliate · indirect
Sold at will 2×
$14.85M 425,000 at 34.94
18.0%
Not planned
23 Feb 2026
Torti Frank President and Vant Chair
Sold on a plan
$16.16M 587,390 at 27.51
4.1%
Planned (10b5-1)
20 Feb 2026
Karp Alexander C. See Remarks
Sold on a plan 10×
$65.96M 493,025 at 133.78
7.1%
Planned (10b5-1)
20 Feb 2026
Cohen Stephen Andrew See Remarks
Sold at will 5×
$43.74M 327,088 at 133.72
99.8%
Sold half or more
20 Feb 2026
Torti Frank President and Vant Chair
Sold on a plan
$27.49M 1,012,610 at 27.15
6.9%
Planned (10b5-1)
20 Feb 2026
Sankar Shyam See Remarks
Sold at will 5×
$22.47M 168,004 at 133.72
20.7%
Not planned
19 Feb 2026
Torti Frank President and Vant Chair
Sold on a plan
$38.39M 1,400,000 at 27.42
9.2%
Planned (10b5-1)
19 Feb 2026
MCKIM ALAN S EXEC CHAIR, CTO. · indirect
Sold at will
$28.11M 100,000 at 281.14
4.2%
Not planned
19 Feb 2026
Sachdev Amit EVP Chief Patient & Ext Af Off
Sold on a plan 8×
$27.48M 58,613 at 468.83
49.9%
Planned (10b5-1)
19 Feb 2026
CONGDON DAVID S Executive Chairman · indirect
Sold at will 2×
$10.13M 52,000 at 194.77
6.8%
Not planned
18 Feb 2026
Venturo Brian M Chief Strategy Officer · indirect
Sold on a plan 9×
$26.60M 281,250 at 94.57
100%
Sold half or more
18 Feb 2026
Sold at will
$11.36M 45,150 at 251.70
29.7%
Not planned
17 Feb 2026
Reuss Mark L President
Sold on a plan 4×
$38.71M 480,724 at 80.52
83.9%
Sold half or more
17 Feb 2026
Sold at will 4×
$36.28M 114,289 at 317.47
75.8%
Sold half or more
17 Feb 2026
WALKER JOHN KENT President, Global Affairs, CLO · indirect
Sold on a plan 8×
$14.34M 47,574 at 301.45
78.2%
Sold half or more
17 Feb 2026
REED JOHN C EVP, Innovative Medicine, R&D
Sold at will 3×
$13.11M 53,931 at 243.00
83.5%
Sold half or more
17 Feb 2026
Gajendra Sanjay President and COO
Sold at will 5×
$11.76M 94,971 at 123.81
5.8%
Not planned
17 Feb 2026
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 2×
$10.82M 22,500 at 480.75
100%
Sold half or more
13 Feb 2026
DONNELLY SCOTT C Executive Chairman
Sold at will 3×
$21.61M 219,619 at 98.41
22.8%
Not planned
13 Feb 2026
Shah Neil B. Chief Commercial Officer · indirect
Sold at will 4×
$13.01M 100,000 at 130.14
16.7%
Not planned
13 Feb 2026
Swanson James D. EVP, CIO
Sold at will 2×
$10.13M 41,559 at 243.73
62.4%
Sold half or more
12 Feb 2026
Retort Vincent SEE REMARKS
Sold on a plan 23×
$26.62M 45,026 at 591.32
30.5%
Planned (10b5-1)
12 Feb 2026
Moeller Jon R Exec. Chairman of the Board
Sold at will
$26.35M 162,232 at 162.45
33.7%
Not planned
11 Feb 2026
ROGERS JOHN F.W. Executive Vice President
Sold at will 18×
$12.61M 13,151 at 959.03
25.2%
Not planned
10 Feb 2026
Goldstein Robert L. Chief Operating Officer
Sold at will 9×
$58.92M 54,190 at 1,087.29
51.3%
Sold half or more
10 Feb 2026
ADKERSON RICHARD C Chairman of the Board
Sold at will
$15.58M 248,031 at 62.80
6.6%
Not planned
9 Feb 2026
Zachary Jennifer EVP, General Counsel
Sold at will 3×
$14.49M 121,573 at 119.15
63.8%
Sold half or more
9 Feb 2026
Schwab Charles R. Co-Chairman · indirect
Sold at will
$13.45M 126,200 at 106.55
0.4%
Not planned
9 Feb 2026
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 2×
$10.68M 22,500 at 474.65
100%
Sold half or more
9 Feb 2026
HAUENSTEIN GLEN W President
Sold at will
$10.32M 137,159 at 75.27
32.9%
Not planned
6 Feb 2026
Phillips Jason President
Sold at will
$30.89M 100,000 at 308.92
88.8%
Sold half or more
6 Feb 2026
Xiao Deming EVP, Global Operations
Sold at will
$26.79M 22,875 at 1,171.16
8.8%
Not planned
6 Feb 2026
Tseng Saria EVP & General Counsel
Sold at will
$26.79M 22,875 at 1,171.16
10.2%
Not planned
6 Feb 2026
Sciammas Maurice EVP, WW Sales & Marketing
Sold at will
$26.79M 22,875 at 1,171.16
11.4%
Not planned
6 Feb 2026
HAUENSTEIN GLEN W President
Sold at will 2×
$21.04M 289,774 at 72.61
41.0%
Not planned
6 Feb 2026
GALLAGHER MAURICE J JR Executive Chairman
Sold at will 2×
$19.99M 175,000 at 114.23
8.2%
Not planned
6 Feb 2026
De Lange Bob Group President
Sold at will
$16.31M 22,656 at 720.11
22.1%
Not planned
5 Feb 2026
MARSHALL RYAN Chief Exec Officer, President
Sold at will
$14.89M 111,250 at 133.86
14.4%
Not planned
Showing 301–350 of 497. ← Newer Page 7 of 10 Older →